News

Neurofibromatosis Type 1 and Plexiform Neurofibromas Publication Trend The graph below shows the total number of publications each year in Neurofibromatosis Type 1 and Plexiform Neurofibromas.
Merck KGaA expands rare tumor portfolio: The $3.4 billion acquisition of SpringWorks Therapeutics adds two FDA-approved therapies: Ogsiveo for desmoid tumors and Gomekli for neurofibromatosis type 1 ...
Plexiform fibromyxoma is a rare primary mesenchymal tumor of the gastrointestinal tract, first reported by Takahashi in 2007 and officially recognized as a subtype of gastric mesenchymal tumor by the ...
In a recent interview, "Modern Family" star Julie Bowen got candid on living with a heart disorder, as well as her upcoming role in "Happy Gilmore 2." ...
Children with cavernous malformations face unique treatment challenges due to factors such as the malformation's location, size, risk of bleeding, and the complexities of pediatric tissue ...
A bacterial sinus infection will often resolve by itself without treatment. However, an untreated bacterial sinus infection can cause complications.
Certain foods have natural decongestant and anti-inflammatory properties that can help clear your nasal passages, reduce sinus pressure, and support overall respiratory health.
Find out what you need to know about mouth breathing in babies. Discover the causes, signs and symptoms, potential health complications, and treatment.
Panelists discuss key lessons learned from previous NF1-associated plexiform neurofibroma therapies, including the limitations of traditional treatments due to high toxicity and limited efficacy ...